NF
GILD icon

NTB Financial’s Gilead Sciences GILD Stock Holding History

NTB Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$434K Sell
7,014
-104
-1% -$6.44K 0.35% 85
2022
Q1 		$423K Sell
7,118
-359
-5% -$22.9K 0.3% 87
2021
Q4 		$543K Buy
+7,477
New +$515K 0.38% 75

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NTB Financial's GILD Position: Q2 2022 in Review

NTB Financial reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2022, selling an estimated $6.44K and leaving 7,014 shares worth $434K. The position accounts for 0.35% of the portfolio, ranked #85.

NTB Financial first reported a position in GILD in Q4 2021 and has held it in 3 quarters since. The position peaked at $543K in Q4 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • NTB Financial held 7,014 shares of Gilead Sciences worth $434K as of Q2 2022.
  • NTB Financial sold 104 Gilead Sciences shares in Q2 2022, an estimated $6.44K.
  • Gilead Sciences made up 0.35% of NTB Financial's portfolio in Q2 2022, its #85 holding.
  • NTB Financial first reported a position in Gilead Sciences in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Gilead Sciences position peaked at $543K in Q4 2021.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.